Cerevel Therapeutics, LLC, 222 Jacobs St, Unit 200, Cambridge, MA 02141, US

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company based in Cambridge, MA. They are dedicated to discovering and developing treatments for neurodegenerative diseases, with a particular focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. Their mission is to support and create more moments for the neurodegenerative disease community by providing innovative therapies. Amylyx is known for their commitment to transparency, realistic expectations, and collaboration in their pursuit of impactful solutions. Driven by a deep understanding of the urgency faced by individuals living with ALS, Amylyx is determined to make a difference in their lives. They strive to provide effective treatments that can significantly improve the quality of life for patients and their caregivers. With a compassionate and dedicated team, Amylyx is at the forefront of research and development in the field of neurodegenerative diseases, working tirelessly to bring hope and relief to those affected.Generated from the website

Thrive Earlier Detection Corp

Philips North America LLC

Electric Charging Station

DW Propco Jk LLC